Berlin Heals Welcomes Rob ten Hoedt as New Chairman
ZUG, Switzerland - Berlin Heals Holding AG is excited to announce the appointment of Rob ten Hoedt as their new Chairman of the Board of Directors. This leadership change signals a pivotal moment for the company as it aims to advance its mission in the medical technology sector.
Rob ten Hoedt is an influential figure with more than three decades of experience in the healthcare industry, having held senior roles at major firms including Medtronic, Vitatron, and Urologix. His extensive background in medical technology is expected to bring invaluable insights to the board.
Leadership Statement on Rob ten Hoedt's Appointment
"We are thrilled to welcome someone of Rob ten Hoedt's caliber to the Board," remarked Marko Bagaric, Co-founder and Member of the Board of Directors. "His global impact on healthcare systems and deep expertise in medical technology will positively affect our progress and help us tackle challenges this year and beyond."
In addition to his new role at Berlin Heals, Mr. ten Hoedt is involved with Medmix and Onward Medical as Chairman and serves on the board of Fagron International. His vast experience will surely help Berlin Heals navigate its ambitious plans for the future.
Rob ten Hoedt's Vision for Berlin Heals
Mr. ten Hoedt expressed his enthusiasm about joining Berlin Heals, saying, "I am very excited to join the Board of Directors at Berlin Heals Holding AG and to contribute to its revolutionary new therapy in Heart Failure. Together, we will strive to bring the life-changing benefits of the C-MIC device to patients worldwide. A thrilling time lies ahead, and it is an honor to be part of it." His vision highlights a commitment to improving the lives of those affected by heart failure through innovative medical solutions.
Understanding C-MIC Therapy
Cardiac Microcurrent (C-MIC) Therapy is a groundbreaking treatment designed to combat Heart Failure. It utilizes a fully implantable device comprising two electrodes connected to a generator that continuously delivers microcurrent to the effected heart tissue. This consistent electrical stimulation has been shown to reduce inflammation and aid in the heart's recovery, enhancing its function and alleviating symptoms.
The latest advancements in the C-MIC therapy involve a significantly less invasive implantation procedure, which can now be performed in an outpatient setting with just conscious sedation. This is a notable progression from the previous methods that required larger surgical interventions.
The Impact of Heart Failure
Heart Failure is an extremely serious health condition affecting millions globally. It occurs when the heart is unable to supply enough blood to meet the body's needs, leading to symptoms such as shortness of breath, fatigue, and more. With approximately 64 million people affected globally and the costs for treating Heart Failure projected to soar to $858 billion annually by 2050, the urgency for effective treatments is greater than ever.
In the developed world, the likelihood of developing Heart Failure in a person's lifetime is approximately one in four, which emphasizes the need for innovative therapeutic approaches. Given its significant impact, addressing Heart Failure is crucial not only for individual health but for overall public health outcomes.
About Berlin Heals Holding AG
Berlin Heals Holding AG is at the forefront of developing novel treatments aimed at reversing the effects of Heart Failure. Following their successful First-In-Human study in 2019 and subsequent positive results from a Randomized Controlled Trial completed in 2024, the company is poised to introduce less invasive procedures for C-MIC therapy. Their headquarters in Zug, Switzerland, is complemented by operational support in Germany and the United States, enabling a wide-reaching impact.
Frequently Asked Questions
Who is Rob ten Hoedt?
Rob ten Hoedt is a seasoned leader in the medical technology field, recently appointed as the Chairman of the Board of Directors at Berlin Heals Holding AG.
What is C-MIC Therapy?
C-MIC Therapy is a treatment for Heart Failure that involves an implantable device delivering microcurrent to improve heart function and reduce symptoms.
What condition does Berlin Heals aim to treat?
Berlin Heals focuses on treating Heart Failure, which affects millions and poses severe health risks across the globe.
What are the implications of Heart Failure?
Heart Failure can lead to symptoms that severely limit daily activities and represents a growing public health concern due to its high prevalence and associated costs.
Where is Berlin Heals Holding AG located?
The company is located in Zug, Switzerland, with additional subsidiaries in Germany and the United States, enhancing its operational footprint.
